Summary

Market Overview:

The global neuromodulation market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.4% during 2023-2028.

Neuromodulation is a medical technique used for the modulation and alteration of nerve activities by delivering electrical or pharmaceutical agents directly to the targeted area. It consists of tiny electrodes that generate electrical stimulation with the help of pulse generators to supplement neurological activities in the patients. The electrodes are generally placed in the nerves, brain, or spinal cord, whereas pulse generators are implanted within the skin. Neuromodulation is widely used to treat depression, chronic pain, epilepsy, tremor, migraine, failed back syndrome, Parkinson's disease, and gastroparesis. It includes the vagal nerve, deep brain, transcranial magnetic, and electrical stimulation. It assists in monitoring nerve activity, alleviating symptoms, and normalizing activity levels in the brain.

Neuromodulation Market Trends:
The rising geriatric population and the increasing prevalence of Alzheimer's and Parkinson's diseases across the globe are key factors driving the market growth. Neuromodulation is widely used to treat overactive bladder, low movement, rigidity, tremor, walking problems, neurodegenerative, and neurological disorders. Moreover, technological innovations, such as the introduction of lithium-ion (Li-ion) batteries that provide high energy density, rechargeability, and enhanced cycling temperature, are providing a considerable boost to the market growth. Additionally, the widespread utilization of spinal cord stimulation (SCS) in various medical problems, such as complex regional pain syndrome, neuropathy, nerve damage, failed-back surgery syndrome, and arachnoiditis, is positively impacting the market growth. Apart from this, the increasing usage of deep brain stimulation (DBS) that delivers low bipolar or monopolar electric impulses and is used in the treatment of depression and obsessive-compulsive disorders (OCD) is creating a positive outlook for the market. Other factors, such as extensive research and development (R&D) activities and significant growth in the healthcare industry, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neuromodulation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology, biomaterial and application.

Breakup by Technology:

Internal Neuromodulation
Spinal Cord Stimulation (SCS)
Deep Brain Stimulation (DBS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)
External Neuromodulation
Transcutaneous Electrical Nerve Stimulation (TENS)
Transcranial Magnetic Stimulation (TMS)
Others

Breakup by Biomaterial:

Metallic Biomaterials
Polymeric Biomaterials
Ceramic Biomaterials

Breakup by Application:

Parkinson's Disease
Epilepsy
Depression
Dystonia
Pain Management
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bioventus Inc., Boston Scientific Corporation, Helius Medical Technologies, Integer Holdings Corporation, LivaNova PLC, Medtronic plc, MicroTransponder Inc., Neuronetics, NeuroPace Inc., NeuroSigma Inc., Nevro Corp.

Key Questions Answered in This Report:
How has the global neuromodulation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global neuromodulation market?
What are the key regional markets?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the biomaterial?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global neuromodulation market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Neuromodulation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 Internal Neuromodulation
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Spinal Cord Stimulation (SCS)
6.1.2.2 Deep Brain Stimulation (DBS)
6.1.2.3 Vagus Nerve Stimulation (VNS)
6.1.2.4 Sacral Nerve Stimulation (SNS)
6.1.2.5 Gastric Electrical Stimulation (GES)
6.1.3 Market Forecast
6.2 External Neuromodulation
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
6.2.2.2 Transcranial Magnetic Stimulation (TMS)
6.2.2.3 Others
6.2.3 Market Forecast
7 Market Breakup by Biomaterial
7.1 Metallic Biomaterials
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Polymeric Biomaterials
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ceramic Biomaterials
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Parkinson's Disease
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Epilepsy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Depression
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Dystonia
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Pain Management
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bioventus Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Boston Scientific Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Helius Medical Technologies
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Integer Holdings Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 LivaNova PLC
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Medtronic plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 MicroTransponder Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Neuronetics
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 NeuroPace Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 NeuroSigma Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Nevro Corp.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials

List of Figures

Figure 1: Global: Neuromodulation Market: Major Drivers and Challenges
Figure 2: Global: Neuromodulation Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Neuromodulation Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Neuromodulation Market: Breakup by Technology (in %), 2022
Figure 5: Global: Neuromodulation Market: Breakup by Biomaterial (in %), 2022
Figure 6: Global: Neuromodulation Market: Breakup by Application (in %), 2022
Figure 7: Global: Neuromodulation Market: Breakup by Region (in %), 2022
Figure 8: Global: Neuromodulation (Internal Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Neuromodulation (Internal Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Neuromodulation (External Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Neuromodulation (External Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Neuromodulation (Metallic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Neuromodulation (Metallic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Neuromodulation (Polymeric Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Neuromodulation (Polymeric Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Neuromodulation (Ceramic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Neuromodulation (Ceramic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Neuromodulation (Parkinson's Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Neuromodulation (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Neuromodulation (Epilepsy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Neuromodulation (Epilepsy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Neuromodulation (Depression) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Neuromodulation (Depression) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Neuromodulation (Dystonia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Neuromodulation (Dystonia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Neuromodulation (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Neuromodulation (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Neuromodulation (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Neuromodulation (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia-Pacific: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia-Pacific: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Neuromodulation Market: Breakup by Country (in %), 2022
Figure 78: Middle East and Africa: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Global: Neuromodulation Industry: SWOT Analysis
Figure 80: Global: Neuromodulation Industry: Value Chain Analysis
Figure 81: Global: Neuromodulation Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neuromodulation Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Neuromodulation Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 3: Global: Neuromodulation Market Forecast: Breakup by Biomaterial (in Million US$), 2023-2028
Table 4: Global: Neuromodulation Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Neuromodulation Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Neuromodulation Market: Competitive Structure
Table 7: Global: Neuromodulation Market: Key Players